Therapeutics of neurotransmitters in Alzheimer's disease

R Kandimalla, PH Reddy - Journal of Alzheimer's Disease, 2017 - content.iospress.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by the
loss of memory, multiple cognitive impairments and changes in the personality and …

Monoaminergic neuropathology in Alzheimer's disease

G Šimić, MB Leko, S Wray, CR Harrington… - Progress in …, 2017 - Elsevier
None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …

The histamine H3 receptor: structure, pharmacology, and function

G Nieto-Alamilla, R Márquez-Gómez… - Molecular …, 2016 - ASPET
Among the four G protein–coupled receptors (H1–H4) identified as mediators of the biologic
effects of histamine, the H3 receptor (H3R) is distinguished for its almost exclusive …

Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin

TC Theoharides, JM Stewart, E Hatziagelaki… - Frontiers in …, 2015 - frontiersin.org
Brain “fog” is a constellation of symptoms that include reduced cognition, inability to
concentrate and multitask, as well as loss of short and long term memory. Brain “fog” …

Whole-brain mapping of histaminergic projections in mouse brain

W Lin, L Xu, Y Zheng, S An, M Zhao… - Proceedings of the …, 2023 - National Acad Sciences
Histamine is a conserved neuromodulator in mammalian brains and critically involved in
many physiological functions. Understanding the precise structure of the histaminergic …

Locus ceruleus norepinephrine release: a central regulator of CNS spatio-temporal activation?

M Atzori, R Cuevas-Olguin… - Frontiers in synaptic …, 2016 - frontiersin.org
Norepinephrine (NE) is synthesized in the Locus Coeruleus (LC) of the brainstem, from
where it is released by axonal varicosities throughout the brain via volume transmission. A …

Comorbidities in a community sample of narcolepsy

A Cohen, J Mandrekar, EKS Louis, MH Silber… - Sleep medicine, 2018 - Elsevier
Study objective To assess comorbidities in a community-based cohort of narcolepsy.
Methods A 2000–2014 community-based narcolepsy cohort was identified in Olmsted …

The roles of histamine and its receptor ligands in central nervous system disorders: An update

W Hu, Z Chen - Pharmacology & therapeutics, 2017 - Elsevier
The neurotransmitter histamine receives less attention compared with other biogenic
amines, because of its moderate action in the central nervous system (CNS). However …

Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics

D Yadav, P Kumar - Neurochemistry international, 2022 - Elsevier
Neurotransmitters are considered as a fundamental regulator in the process of neuronal
growth, differentiation and survival. Parkinson's Disease (PD) occurs due to extensive …

Histamine, neuroinflammation and neurodevelopment: a review

E Carthy, T Ellender - Frontiers in neuroscience, 2021 - frontiersin.org
The biogenic amine, histamine, has been shown to critically modulate inflammatory
processes as well as the properties of neurons and synapses in the brain, and is also …